RankingsPricing
  1. US-listed companies
  2. IONIS PHARMACEUTICALS INC
  3. Financials
  4. Total assets

IONIS PHARMACEUTICALS INCIONS

Market cap
$12.3B
P/E ratio
SummaryFinancials
Period EndTotal assets (Million USD)YoY (%)
Dec 31, 20243,004+0.45%
Dec 31, 20232,990+18.00%
Dec 31, 20222,534-2.98%
Dec 31, 20212,612+9.29%
Dec 31, 20202,390-26.08%
Dec 31, 20193,233+21.19%
Dec 31, 20182,668+101.80%
Dec 31, 20171,322+44.88%
Dec 31, 2016912-4.56%
Dec 31, 2015956+0.03%
Dec 31, 2014956+12.83%
Dec 31, 2013847+55.25%
Dec 31, 2012546+12.54%
Dec 31, 2011485-11.91%
Dec 31, 2010550

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)